tiprankstipranks
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF
US Market
HAVLF
HAVN Life Sciences
RESEARCH TOOLSreports

HAVN Life Sciences (HAVLF) Income Statement

32 Followers

HAVN Life Sciences Income Statement

Last quarter (Q4 2022), HAVN Life Sciences's total revenue was C$216.38K, an increase of Infinity% from the same quarter last year. In Q4, HAVN Life Sciences's net income was C$-21.05M. See HAVN Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 21Apr 20
Total Revenue
C$ 276.47KC$ 0.00
Gross Profit
C$ 89.69KC$ 0.00
Operating Expenses
C$ 9.90MC$ 41.12K
Depreciation and Amortization
C$ 575.62KC$ 171.86K
EBITDA
C$ -21.80MC$ -40.58K
Operating Income
C$ -9.81MC$ -40.58K
Other Income/Expenses
C$ -12.63MC$ -446.34K
Pretax Income
C$ -22.44MC$ -40.58K
Net Income
C$ -22.44MC$ -40.58K
Per Share Metrics
Basic EPS
C$ -5.25C$ -0.39
Diluted EPS
C$ -5.25C$ -0.39
Weighted Average Shares Outstanding
 4.28M 104.05K
Weighted Average Shares Outstanding (Diluted)
 4.28M 104.05K
Currency in CAD

HAVN Life Sciences Earnings and Revenue History